Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 56

Sort by

Sort Order Select

Journal Articles

Identification of T-Cell Receptors Specific to Antigens Presented By HLA-B4002 and B5401 in Acquired Aplastic Anemia

Kohei Hosokawa, MD PhD, Eiji Kobayashi, PhD, Yoshiki Akatsuka, MD PhD, Luis Espinoza, MD PhD, Noriharu Nakagawa, MD, Tanabe Mikoto, MD, Noriaki Tsuji, MD, Takeshi Yoroidaka, MD, Hiroki Mizumaki, MD, Thi Mai Anh Nguyen, MD, Takamasa Katagiri, PhD, Kiyomi Shitaoka, PhD, Hiroshi Hamana, PhD, Hiroyuki Kishi, PhD, Shinji Nakao, MD PhD

Blood (2019) 134 (Supplement_1): 3751.

https://doi.org/10.1182/blood-2019-125685

Published: 2019

Journal Articles

Characterisation of Citrullinated TFPI and Truncated TFPI Constructs By PAD4 in Model and Plasma Systems

M.G.L. Christella D. Thomassen, Dennis P.L. Suylen, Tilman M. Hackeng, PhD, Rory R. Koenen, PhD

Blood (2019) 134 (Supplement_1): 2390.

https://doi.org/10.1182/blood-2019-131190

Published: 2019

Journal Articles

In Vitro and In Vivo Characterization of Marstacimab, an Anti-TFPI Antibody

Chuenlei Parng, PhD, Macy Jin, PhD, Matthew Holsti, PhD, Susan Benard, Swapnil Rakhe, MS, Sunita R. Patel-Hett, PhD, Alison Joyce, Rob Webster, Debra D Pittman, MS

Blood (2019) 134 (Supplement_1): 2391.

https://doi.org/10.1182/blood-2019-130327

Published: 2019

Journal Articles

Antithrombin- and Heparin-Binding Exosites Regulate Extravascular Binding and Clearance of Factor IXa

Pamela Westmark, PhD, John P. Sheehan, MD

Blood (2019) 134 (Supplement_1): 2392.

https://doi.org/10.1182/blood-2019-131580

Published: 2019

Journal Articles

NMR structure determination of Ixolaris and factor X(a) interaction reveals a noncanonical mechanism of Kunitz inhibition

Viviane S. De Paula, Nikolaos G. Sgourakis, Ivo M. B. Francischetti, Fabio C. L. Almeida, Robson Q. Monteiro, Ana Paula Valente

Blood (2019) 134 (8): 699–708.

https://doi.org/10.1182/blood.2018889493

Published: 2019

Includes: Supplemental data

Journal Articles

Bad weed: synthetic cannabinoid–associated coagulopathy

Gowthami M. Arepally, Thomas L. Ortel

Blood (2019) 133 (9): 902–905.

https://doi.org/10.1182/blood-2018-11-876839

Published: 2019

Journal Articles

Neutrophil KLF2 Regulates Arterial and Venous Thrombosis

Lalitha V. Nayak, MD, Stephanie Lapping, MS, Andrei Maiseyeu, Alvin H. Schmaier, MD, Mukesh Jain

Blood (2018) 132 (Supplement 1): 75.

https://doi.org/10.1182/blood-2018-99-113719

Published: 2018

Journal Articles

Role of Protease Exosites for In Vivo Hemostatic Activity and Clearance of FIX

Pamela Westmark, PhD, John Sheehan, MD

Blood (2018) 132 (Supplement 1): 1166.

https://doi.org/10.1182/blood-2018-99-120212

Published: 2018

Journal Articles

BFPI: A Minimal Prothrombinase Inhibitor from the Saliva of Simulium Vittatum

Jeremy P. Wood, PhD, Xiao H. Song, Alan E. Mast, MDPhD

Blood (2018) 132 (Supplement 1): 1163.

https://doi.org/10.1182/blood-2018-99-118666

Published: 2018

Journal Articles

Pharmacodynamics, Pharmacokinetics and Safety of Bay 1093884, an Antibody Directed Against Human TFPI, in Patients with Factor VIII or IX Deficiency (With and Without Inhibitors): A Phase 1 Study

Pratima Chowdary, MD, Toshko Jelev Lissitchkov, MD, Stefan Willmann, Dr, Stephan Schwers, PhD, Lisa A. Michaels, Anita Shah

Blood (2018) 132 (Supplement 1): 1176.

https://doi.org/10.1182/blood-2018-99-114683

Published: 2018

Journal Articles

Prothrombinase Inhibition By Tfpiα Requires Three Distinct Interactions with Factors Va and X

Jeremy P. Wood, PhD, Alan E. Mast, MDPhD

Blood (2017) 130 (Supplement 1): 1060.

https://doi.org/10.1182/blood.V130.Suppl_1.1060.1060

Published: 2017

Journal Articles

Low TFPI Mice in Models of Atherosclerosis and Endotoxemia

Thomas James Girard, George J. Broze, Jr., MD, Nina M Lasky, Kristin Grunz

Blood (2017) 130 (Supplement 1): 2336.

https://doi.org/10.1182/blood.V130.Suppl_1.2336.2336

Published: 2017

Journal Articles

Complete TFPI Gene-Disruption Is More Severe Than TFPI Kunitz-1 Gene-Deletion in Mice

Thomas James Girard, Nina M Lasky, George J. Broze, Jr., MD

Blood (2017) 130 (Supplement 1): 2335.

https://doi.org/10.1182/blood.V130.Suppl_1.2335.2335

Published: 2017

Journal Articles

Kunitz 3-Selective but Not Kunitz 2-Selective TFPI Inhibitors Cause Release of Tfpiα from Endothelial Cells: Insights into the Release Mechanism

Julie A. Peterson, PhD, Cecilia Augustsson, PhD, Susan A Maroney, DVM, PhD, Helle Heibroch Petersen, Ida Hilden, Alan Mast, Wes Zwifelhofer, BS

Blood (2016) 128 (22): 2558.

https://doi.org/10.1182/blood.V128.22.2558.2558

Published: 2016

Journal Articles

DYRK2 Inhibits the Self-Renewal of Leukemic Stem Cells in Chronic Myeloid Leukemia By Inducing Degradation of c-Myc Downstream of the Reprogramming Factor KLF4

Chun Shik Park, PhD, Ye Shen, BS, Koramit Suppipat, MD, Andrew Lewis, B.S., Julie Tomolonis, B.S., Monica Puppi, M.Sc., toni-Ann Mistretta, PhD, Leyuan Ma, Michael R Green, MD PhD, Daniel Lacorazza, PhD

Blood (2016) 128 (22): 1879.

https://doi.org/10.1182/blood.V128.22.1879.1879

Published: 2016

Journal Articles

Use of Marijuana in Patients with Sickle Cell Disease Increased the Frequency of Hospitalization for Acute Painful Vaso-Occlusive Crises

Samir K. Ballas, MD

Blood (2016) 128 (22): 2498.

https://doi.org/10.1182/blood.V128.22.2498.2498

Published: 2016

Journal Articles

The Human Kell Blood Group Binds the Erythroid 4.1R Protein: New Insights into the 4.1R-Dependent Red Cell Membrane Complex

Slim Azouzi, Emmanuel Collec, Narla Mohandas, DSc, Xiuli An, MD PhD, Yves Colin Aronovicz, Caroline Le Van Kim

Blood (2015) 126 (23): 3334.

https://doi.org/10.1182/blood.V126.23.3334.3334

Published: 2015

Journal Articles

TFPIα Has Reduced Ability to Inhibit FV Leiden

Jeremy P. Wood, PhD, Lisa Baumann Kreuziger, MD, Rodney M. Camire, PhD, Alan E. Mast, MD PhD

Blood (2015) 126 (23): 423.

https://doi.org/10.1182/blood.V126.23.423.423

Published: 2015

Journal Articles

HIF1-Alpha and MYC Transcription Factor Signatures in B-Cell Acute Lymphoblastic Leukemia Are Associated with Positive Minimal Residual Disease Status: Therapeutic Implications

Tomasz Sewastianik, MSc, Patryk Gorniak, PhD, Przemyslaw Kiliszek, MSc, Anna Polak, MSc, Emilia Bialopiotrowicz, PhD, Ewa Jablonska, PhD, Maciej Szydlowski, PhD, Ewa Lech-Maranda, MD PhD, Katarzyna Borg, PhD, Hanna Makuch-Lasica, MSc, Adam Zabek, MSc, Piotr Mlynarz, PhD, Tomasz Stoklosa, MD PhD, Sebastian Giebel, MD PhD, Krzysztof Warzocha, MD PhD, Przemyslaw Juszczynski, MD PhD

Blood (2015) 126 (23): 1436.

https://doi.org/10.1182/blood.V126.23.1436.1436

Published: 2015

Journal Articles

Cannabinoids As Antimyeloma Agents: a New Approach for the Treatment of Multiple Myeloma

María Victoria Barbado, PhD, Mayte Medrano, Jose Ignacio Piruat, PhD, Ivan Valle, Teresa Caballero, PhD, Isabel Álvarez, Jose Antonio Perez-Simón, MDPhD

Blood (2014) 124 (21): 4724.

https://doi.org/10.1182/blood.V124.21.4724.4724

Published: 2014

NARROW

Identification of T-Cell Receptors Specific to Antigens Presented By HLA-B4002 and B5401 in Acquired Aplastic Anemia

Characterisation of Citrullinated TFPI and Truncated TFPI Constructs By PAD4 in Model and Plasma Systems

In Vitro and In Vivo Characterization of Marstacimab, an Anti-TFPI Antibody

Antithrombin- and Heparin-Binding Exosites Regulate Extravascular Binding and Clearance of Factor IXa

NMR structure determination of Ixolaris and factor X(a) interaction reveals a noncanonical mechanism of Kunitz inhibition

Bad weed: synthetic cannabinoid–associated coagulopathy

Neutrophil KLF2 Regulates Arterial and Venous Thrombosis

Role of Protease Exosites for In Vivo Hemostatic Activity and Clearance of FIX

BFPI: A Minimal Prothrombinase Inhibitor from the Saliva of Simulium Vittatum

Pharmacodynamics, Pharmacokinetics and Safety of Bay 1093884, an Antibody Directed Against Human TFPI, in Patients with Factor VIII or IX Deficiency (With and Without Inhibitors): A Phase 1 Study

Prothrombinase Inhibition By Tfpiα Requires Three Distinct Interactions with Factors Va and X

Low TFPI Mice in Models of Atherosclerosis and Endotoxemia

Complete TFPI Gene-Disruption Is More Severe Than TFPI Kunitz-1 Gene-Deletion in Mice

Kunitz 3-Selective but Not Kunitz 2-Selective TFPI Inhibitors Cause Release of Tfpiα from Endothelial Cells: Insights into the Release Mechanism

DYRK2 Inhibits the Self-Renewal of Leukemic Stem Cells in Chronic Myeloid Leukemia By Inducing Degradation of c-Myc Downstream of the Reprogramming Factor KLF4

Use of Marijuana in Patients with Sickle Cell Disease Increased the Frequency of Hospitalization for Acute Painful Vaso-Occlusive Crises

The Human Kell Blood Group Binds the Erythroid 4.1R Protein: New Insights into the 4.1R-Dependent Red Cell Membrane Complex

TFPIα Has Reduced Ability to Inhibit FV Leiden

HIF1-Alpha and MYC Transcription Factor Signatures in B-Cell Acute Lymphoblastic Leukemia Are Associated with Positive Minimal Residual Disease Status: Therapeutic Implications

Cannabinoids As Antimyeloma Agents: a New Approach for the Treatment of Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only